BASELINE CHARACTERISTICS FOR PATIENTS WITH MILD ALZHEIMER’S DISEASE ENROLLED IN THE PHASE IIA TRIAL OF ACTIVE IMMUNOTHERAPEUTIC VACCINE UB-311

Hui Jing Yu; Hui-Chen Chen; Jacob Hesterman; Xue Wang; Roger N. Gunn; Ajay Verma

首页> 外文期刊>Alzheimer’s & dementia: the journal of the Alzheimer’s Association >BASELINE CHARACTERISTICS FOR PATIENTS WITH MILD ALZHEIMER’S DISEASE ENROLLED IN THE PHASE IIA TRIAL OF ACTIVE IMMUNOTHERAPEUTIC VACCINE UB-311

【24h】

BASELINE CHARACTERISTICS FOR PATIENTS WITH MILD ALZHEIMER’S DISEASE ENROLLED IN THE PHASE IIA TRIAL OF ACTIVE IMMUNOTHERAPEUTIC VACCINE UB-311

机译：患有轻度阿尔茨海默病患者的基线特征，患有活性免疫治疗疫苗UB-311的IIa IIA试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Alzheimer’s & dementia: the journal of the Alzheimer’s Association》 |2018年第7期|共1页
作者
Hui Jing Yu; Hui-Chen Chen; Jacob Hesterman; Xue Wang; Roger N. Gunn; Ajay Verma;
展开▼
作者单位

United Neuroscience Inc;

United Neuroscience Ltd;

inviCRO LLC;

inviCRO LLC;

Invicro;

United Neuroscience Inc;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. BASELINE CHARACTERISTICS FOR PATIENTS WITH MILD ALZHEIMER’S DISEASE ENROLLED IN THE PHASE IIA TRIAL OF ACTIVE IMMUNOTHERAPEUTIC VACCINE UB-311 [J] . Hui Jing Yu, Hui-Chen Chen, Jacob Hesterman, Alzheimer’s & dementia: the journal of the Alzheimer’s Association . 2018,第7期

机译：患有轻度阿尔茨海默病患者的基线特征，患有活性免疫治疗疫苗UB-311的IIa IIA试验
2. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC [J] . Rachel Sanborn, Brian Boulmay, Rui Li, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：单独使用同种异体运球疫苗（DPV-001）或GM-CSF或咪喹莫特用于IIIa或IIIb期NSCLC辅助治疗的环磷酰胺II期试验的患者的免疫应答初步分析
3. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC [J] . Traci Hilton, Rachel Sanborn, Brian Boulmay, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：一项单独应用异体DRibble疫苗（DPV-001）或联合GM-CSF或咪喹莫特用于IIIA或IIIB期NSCLC辅助治疗的环磷酰胺II期试验患者的免疫应答初步分析
4. SPARSE BUMP MODELING OF MILDAD PATIENTS: Modeling Transient Oscillations in the EEG of Patients with Mild Alzheimer's Disease [C] . Francois-Benoit Vialatte, Charles Francois Vincent Latchoumane, Nigel Hudson, International Conference on Bio-inspired Systems and Signal Processing . 2010

机译：MIDAD患者的稀疏凹凸模型：患有轻度阿尔茨海默病患者脑脑血管震荡的模拟
5. Investigating Nutritional Status in Moderate to Severe Alzheimer's Disease Patients Enrolled in a Randomized Controlled Trial with Nabilone [D] . Sherman, Chelsea. 2018

机译：研究中度至重度阿尔茨海默氏病患者的营养状况，该患者参加了纳比隆的随机对照试验
6. Safety tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised double-blind placebo-controlled phase I trial [O] . Ana-María Lacosta, María Pascual-Lucas, Pedro Pesini, 2018

机译：活性抗Aβ40疫苗（ABvac40）在阿尔茨海默氏病患者中的安全性耐受性和免疫原性：一项随机双盲安慰剂对照的I期试验
7. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC [O] . 2015

机译：单独使用同种异体运球疫苗（DPV-001）或GM-CSF或咪喹莫特进行IIIa或IIIb期NSCLC辅助治疗的环磷酰胺II期试验的患者的免疫应答初步分析

BASELINE CHARACTERISTICS FOR PATIENTS WITH MILD ALZHEIMER’S DISEASE ENROLLED IN THE PHASE IIA TRIAL OF ACTIVE IMMUNOTHERAPEUTIC VACCINE UB-311

著录项

相似文献

相关主题

期刊订阅